Loss of function of GATA3 induces basal-like mammary tumors
Authors:
Open Access
- 1 January 2022
- journal article
- research article
- Published by Ivyspring International Publisher in Theranostics
- Vol. 12 (2) , 720-733
Abstract
Purpose: GATA3 is a transcription factor essential for mammary luminal epithelial cell differentiation. Expression of GATA3 is absent or significantly reduced in basal-like breast cancers. Gata3 loss-of-function impairs cell proliferation, making it difficult to investigate the role of GATA3 deficiency in vivo. We previously demonstrated that CDK inhibitor p18INK4c (p18) is a downstream target of GATA3 and restrains mammary epithelial cell proliferation and tumorigenesis. Whether and how loss-of-function of GATA3 results in basal-like breast cancers remains elusive.Keywords
This publication has 58 references indexed in Scilit:
- Genetic Predisposition Directs Breast Cancer Phenotype by Dictating Progenitor Cell FateCell Stem Cell, 2011
- Higher levels of GATA3 predict better survival in women with breast cancerHuman Pathology, 2010
- GATA3 in development and cancer differentiation: Cells GATA have it!Journal of Cellular Physiology, 2009
- CDK Inhibitor p18INK4c Is a Downstream Target of GATA3 and Restrains Mammary Luminal Progenitor Cell Proliferation and TumorigenesisCancer Cell, 2009
- GATA-3 Links Tumor Differentiation and Dissemination in a Luminal Breast Cancer ModelCancer Cell, 2008
- GATA-3 Maintains the Differentiation of the Luminal Cell Fate in the Mammary GlandCell, 2006
- Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her2/neu-overexpressing phenotypesHuman Pathology, 2006
- Phenotypic evaluation of the basal-like subtype of invasive breast carcinomaLaboratory Investigation, 2005
- GATA3 haplo-insufficiency causes human HDR syndromeNature, 2000
- Targeted disruption of the GATA3 gene causes severe abnormalities in the nervous system and in fetal liver haematopoiesisNature Genetics, 1995